{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:53:59Z","timestamp":1787586839866,"version":"build-2736575974"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:00:00Z","timestamp":1751673600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejim.2025.07.003","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T14:03:59Z","timestamp":1752588239000},"page":"106407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Deterioration of renal function is delayed in patients with atrial fibrillation treated with direct oral anticoagulants compared to vitamin K antagonists: systematic review and meta-analysis"],"prefix":"10.1016","volume":"141","author":[{"given":"Anastasia","family":"Adamou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2970-088X","authenticated-orcid":false,"given":"Ioannis","family":"Kyriakoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2125-5825","authenticated-orcid":false,"given":"Polyxeni","family":"Botou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3745-401X","authenticated-orcid":false,"given":"Ioannis","family":"Belios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6458-8201","authenticated-orcid":false,"given":"Iliana","family":"Stamatiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1596-9466","authenticated-orcid":false,"given":"David Dimitris","family":"Chlorogiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5952-5106","authenticated-orcid":false,"given":"Theodoros","family":"Mavridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0629-9248","authenticated-orcid":false,"given":"George","family":"Ntaios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2025.07.003_bib0001","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ki.2011.44","article-title":"Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate","volume":"80","author":"Brodsky","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2025.07.003_bib0002","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.thromres.2022.12.002","article-title":"Anticoagulant-related nephropathy induced by direct-acting oral anticoagulants: clinical characteristics, treatments and outcomes","volume":"222","author":"Chen","year":"2023","journal-title":"Thromb Res"},{"key":"10.1016\/j.ejim.2025.07.003_bib0003","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.blre.2012.03.002","article-title":"Vascular calcification: the price to pay for anticoagulation therapy with vitamin K-antagonists","volume":"26","author":"Chatrou","year":"2012","journal-title":"Blood Rev"},{"key":"10.1016\/j.ejim.2025.07.003_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1244098","article-title":"Distinct pleiotropic effects of direct oral anticoagulants on cultured endothelial cells: a comprehensive review","volume":"14","author":"Atzemian","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ejim.2025.07.003_bib0005","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1080\/14656566.2018.1515913","article-title":"Non-vitamin-K oral anticoagulants (NOACs) for the prevention of secondary stroke","volume":"19","author":"Diener","year":"2018","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ejim.2025.07.003_bib0006","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1177\/1747493017700663","article-title":"Nonvitamin-K-antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack: an updated systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"Ntaios","year":"2017","journal-title":"Int J Stroke"},{"key":"10.1016\/j.ejim.2025.07.003_bib0007","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1161\/STROKEAHA.117.017549","article-title":"Real-world setting comparison of nonvitamin-K antagonist oral anticoagulants versus vitamin-K antagonists for stroke prevention in atrial fibrillation: a systematic review and meta-analysis","volume":"48","author":"Ntaios","year":"2017","journal-title":"Stroke."},{"key":"10.1016\/j.ejim.2025.07.003_bib0008","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1681\/ASN.2018070741","article-title":"Anticoagulant-related nephropathy","volume":"29","author":"Brodsky","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2025.07.003_bib0009","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/j.jacc.2015.03.577","article-title":"Changes in renal function in patients with atrial fibrillation: an analysis from the RE-LY trial","volume":"65","author":"Bohm","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2025.07.003_bib0010","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1136\/heartjnl-2021-319297","article-title":"Tarng DC. Associations of atrial fibrillation with renal function decline in patients with chronic kidney disease","volume":"108","author":"Chen","year":"2022","journal-title":"Heart"},{"key":"10.1016\/j.ejim.2025.07.003_bib0011","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12882-023-03449-y","article-title":"Changes in estimated glomerular filtration rate before and after the first visit for atrial fibrillation","volume":"25","author":"Yasuoka","year":"2024","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.ejim.2025.07.003_bib0012","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.amjcard.2012.12.045","article-title":"Renal impairment in a \"real-life\" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding)","volume":"111","author":"Roldan","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejim.2025.07.003_bib0013","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejim.2023.08.020","article-title":"Efficacy and safety of direct oral anticoagulants vs vitamin K antagonists in patients with atrial fibrillation and end-stage renal disease on hemodialysis: a systematic review and meta-analysis","volume":"119","author":"Kyriakoulis","year":"2024","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2025.07.003_bib0014","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","volume":"74","author":"January","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2025.07.003_bib0015","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1093\/europace\/euab218","article-title":"European heart rhythm association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: comment-authors' reply","volume":"23","author":"Steffel","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.ejim.2025.07.003_bib0016","article-title":"Oral anticoagulants and relative risk of acute kidney injury in patients with atrial fibrillation: a systematic review and network meta-analysis","volume":"15","author":"Luo","year":"2022","journal-title":"Am Heart J Plus"},{"key":"10.1016\/j.ejim.2025.07.003_bib0017","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019609","article-title":"Non-vitamin K antagonist oral anticoagulants provide less adverse renal outcomes than warfarin In Non-valvular atrial fibrillation: a systematic review and MetaAnalysis","volume":"10","author":"Sitticharoenchai","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ejim.2025.07.003_bib0018","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.thromres.2018.12.010","article-title":"Decreased risk of renal impairment in atrial fibrillation patients receiving non-vitamin K antagonist oral anticoagulants: a pooled analysis of randomized controlled trials and real-world studies","volume":"174","author":"Zhang","year":"2019","journal-title":"Thromb Res"},{"key":"10.1016\/j.ejim.2025.07.003_bib0019","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2025.07.003_bib0020","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1053\/j.ajkd.2014.07.030","article-title":"GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration","volume":"64","author":"Levey","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ejim.2025.07.003_bib0021","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ejim.2025.07.003_bib0022","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2025.07.003_bib0023","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"10.1016\/j.ejim.2025.07.003_bib0024","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2025.07.003_bib0025","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1037\/1082-989X.6.3.203","article-title":"The power of statistical tests in meta-analysis","volume":"6","author":"Hedges","year":"2001","journal-title":"Psychol Methods"},{"key":"10.1016\/j.ejim.2025.07.003_bib0026","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2025.07.003_bib0027","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1016\/j.jacc.2017.09.1087","article-title":"Renal outcomes in anticoagulated patients with atrial fibrillation","volume":"70","author":"Yao","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2025.07.003_bib0028","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14086","article-title":"Cardiac and renal outcomes of direct oral anticoagulants in patients with atrial fibrillation","volume":"54","author":"Wang","year":"2024","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ejim.2025.07.003_bib0029","doi-asserted-by":"crossref","first-page":"sfad252","DOI":"10.1093\/ckj\/sfad252","article-title":"Oral anticoagulant treatment and risk of kidney disease-a nationwide, population-based cohort study","volume":"17","author":"Vestergaard","year":"2024","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ejim.2025.07.003_bib0030","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1053\/j.ajkd.2022.07.017","article-title":"Cardiorenal outcomes among patients with atrial fibrillation treated with oral anticoagulants","volume":"81","author":"Trevisan","year":"2023","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ejim.2025.07.003_bib0031","first-page":"24","article-title":"Renal outcomes in Asian patients receiving oral anticoagulants for non-valvular atrial fibrillation","volume":"28","author":"Shahzada","year":"2022","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.ejim.2025.07.003_bib0032","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1040834","article-title":"Renal outcomes of rivaroxaban compared with warfarin in Asian patients with nonvalvular atrial fibrillation: a nationwide population-based cohort study","volume":"10","author":"Lee","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.ejim.2025.07.003_bib0033","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/ehjqcco\/qcz047","article-title":"Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes","volume":"6","author":"Hernandez","year":"2020","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.ejim.2025.07.003_bib0034","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1080\/03007995.2021.1947217","article-title":"Kidney, limb and ophthalmic complications, and death in patients with nonvalvular atrial fibrillation and type 2 diabetes prescribed rivaroxaban or warfarin: an electronic health record analysis","volume":"37","author":"Costa","year":"2021","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ejim.2025.07.003_bib0035","doi-asserted-by":"crossref","DOI":"10.1177\/1076029619868535","article-title":"Rivaroxaban's impact on renal decline in patients with nonvalvular atrial fibrillation: a US MarketScan Claims Database analysis","volume":"25","author":"Coleman","year":"2019","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.ejim.2025.07.003_bib0036","article-title":"The change of renal functions after nonvitamin K oral anticoagulants in patients with atrial fibrillation","volume":"35","author":"Chantrarat","year":"2021","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.ejim.2025.07.003_bib0037","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/17512433.2022.2070151","article-title":"Comparing the renal outcomes in patients with atrial fibrillation receiving different oral anticoagulants","volume":"15","author":"Bezabhe","year":"2022","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.ejim.2025.07.003_bib0038","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijcard.2022.01.063","article-title":"Renal decline in patients with non-valvular atrial fibrillation treated with rivaroxaban or warfarin: a population-based study from the United Kingdom","volume":"352","author":"Gonzalez Perez","year":"2022","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ejim.2025.07.003_bib0039","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/jamacardio.2016.1170","article-title":"Efficacy and safety of Apixaban compared with Warfarin in patients with atrial fibrillation in relation to renal function over time: insights from the ARISTOTLE randomized clinical trial","volume":"1","author":"Hijazi","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ejim.2025.07.003_bib0040","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.chest.2016.07.013","article-title":"Direct comparison of Dabigatran, Rivaroxaban, and Apixaban for effectiveness and safety in nonvalvular atrial fibrillation","volume":"150","author":"Noseworthy","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.ejim.2025.07.003_bib0041","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1125576","article-title":"Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation: a nationwide cohort study","volume":"14","author":"Grymonprez","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ejim.2025.07.003_bib0042","doi-asserted-by":"crossref","first-page":"e7097","DOI":"10.1136\/bmj.e7097","article-title":"Primary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysis","volume":"345","author":"Rasmussen","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2025.07.003_bib0043","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.krcp.2014.11.001","article-title":"Anticoagulants and acute kidney injury: clinical and pathology considerations","volume":"33","author":"Brodsky","year":"2014","journal-title":"Kidney Res Clin Pract"},{"key":"10.1016\/j.ejim.2025.07.003_bib0044","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.xkme.2019.03.002","article-title":"Anticoagulant-related nephropathy in kidney biopsy: a single-center report of 41 cases","volume":"1","author":"Brodsky","year":"2019","journal-title":"Kidney Med"},{"key":"10.1016\/j.ejim.2025.07.003_bib0045","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1093\/eurheartj\/ehr226","article-title":"Patients using vitamin K antagonists show increased levels of coronary calcification: an observational study in low-risk atrial fibrillation patients","volume":"32","author":"Weijs","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2025.07.003_bib0046","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.amjmed.2015.11.032","article-title":"Warfarin and vascular calcification","volume":"129","author":"Poterucha","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/j.ejim.2025.07.003_bib0047","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1007\/s12325-023-02544-8","article-title":"Prescription of DOACs in patients with atrial fibrillation at different stages of renal insufficiency","volume":"40","author":"Hahn","year":"2023","journal-title":"Adv Ther"},{"key":"10.1016\/j.ejim.2025.07.003_bib0048","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.blre.2011.07.001","article-title":"Bleeding and thrombotic complications of kidney disease","volume":"25","author":"Pavord","year":"2011","journal-title":"Blood Rev"},{"key":"10.1016\/j.ejim.2025.07.003_bib0049","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1053\/j.ajkd.2017.08.016","article-title":"Incident atrial fibrillation and the risk of congestive heart failure, myocardial infarction, end-stage kidney disease, and mortality among patients with a decreased estimated GFR","volume":"71","author":"Massicotte-Azarniouch","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ejim.2025.07.003_bib0050","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/clc.23196","article-title":"Anticoagulation in chronic kidney disease: from guidelines to clinical practice","volume":"42","author":"Aursulesei","year":"2019","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.ejim.2025.07.003_bib0051","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.2237","article-title":"Anticoagulation for stroke prevention in patients with atrial fibrillation and end-stage renal disease-first, do No harm","volume":"3","author":"Belley-Cote","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ejim.2025.07.003_bib0052","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ejim.2024.03.014","article-title":"Sex-based differences in the comprehensive geriatric assessment in elderly hospitalized patients with non-valvular atrial fibrillation","volume":"125","author":"Armentaro","year":"2024","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2025.07.003_bib0053","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1111\/bcp.14350","article-title":"Association of different oral anticoagulants use with renal function worsening in patients with atrial fibrillation: a multicentre cohort study","volume":"86","author":"Pastori","year":"2020","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ejim.2025.07.003_bib0054","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1210560","article-title":"Medium-term and long-term renal function changes with direct oral anticoagulants in elderly patients with atrial fibrillation","volume":"14","author":"Armentaro","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ejim.2025.07.003_bib0055","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/bcp.16010","article-title":"Appropriateness of direct oral anticoagulant prescribing in older subjects with atrial fibrillation discharged from acute medical wards","volume":"90","author":"De Vincentis","year":"2024","journal-title":"Br J Clin Pharmacol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620525002742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620525002742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T10:15:19Z","timestamp":1762337719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620525002742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":55,"alternative-id":["S0953620525002742"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2025.07.003","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deterioration of renal function is delayed in patients with atrial fibrillation treated with direct oral anticoagulants compared to vitamin K antagonists: systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2025.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.","name":"copyright","label":"Copyright"}],"article-number":"106407"}}